ACOR Faqs

ACOR Faqs

Page Last Modified on: May 25, 2007

	General ACOR FAQs
	What is ACOR? What are the ACOR Mailing Lists? How do I contact ACOR?

	Mailing Lists FAQs
	How do I find a list? How do I join a list? How do I leave a list? How do I write to the list? How do I register a password? How do I search the list archives? How do I contact the listowner(s)?
	Solving Problems with your Subscription
	I'm not getting mail from the list! I can't post to the list! I am having problems signing off! I am having problems subscribing! I'm changing email addresses! I would like to stop mail temporarily! I would like to resume mail delivery! I want to receive one big message every day! I would like to stop digest mode and resume mail delivery! I'm still stuck! I need help from the listowners

Scientific news

Radiology procedure may help increase long-term survival in patients with severe liver cancer

In patients with unresectable (unable to be removed by surgery) liver cancer, an interventional radiology procedure called triple-drug transcatheter ...

Nov 20, 2009

[Full Story] | [More Science] | [More News]

What's new @ ACOR

ACOR Research

How Cancer Survivors Provide Support on Cancer-Related Internet Mailing Lists

ACOR Reference Wiki on Medical Mailing Lists

The e-Patients White Paper Wiki

The e-Patients Blog

New Groups

Children with ALCL (Anaplastic Large Cell Lymphoma)

DOLOR-FORO: Spanish-speaking Pain Community

More ACOR

FAQs

About ACOR

ACOR in the News

You are not Alone!

Donate to ACOR

Last week, ACOR.org delivered over 1,5 million email to cancer patients across the globe	Last updated a minute ago
Privacy/ Use Policies \| About ACOR \| ACOR Research Center © 1995-2009 ACOR, Inc. All rights reserved. ACOR and ACOR.org are registered trademarks of the Association of Cancer Online Resources, Inc. A non-profit organization using the Internet to maximize access to quality care and support for anyone affected by cancer. 173 Duane St, Suite 3A, New York, NY 10013	E-Mail Newsletter Sign-Up \| Contact Us \| Home \| Back to Top